Table 1. Characteristics of equines with solid tumors treated with ECT single modality.
| Breed | Sex | Agea | Tumor type | Site | Therapy | Outcomeb |
|---|---|---|---|---|---|---|
| Arabian | F | 4 | Melanoma | Parotid | ECT × 2 | PR 48 |
| ED | MC | 16 | Melanoma | Perianal | ECT × 8c | PR 60 |
| ED | M | 10 | Melanoma | Perianal | ECT × 3 | CR 36 |
| BSH | M | 10 | Melanoma | Perianal | ECT × 2 | CR 24 |
| Lipizzaner | M | 17 | Melanoma | Lip | ECT × 2 | PR 18 |
| ISH | F | 12 | Melanoma | Parotid | ECT × 2 | SD 7 |
| ED | MC | 21 | Melanoma | Axilla | ECT × 2 | PR 12 |
| Arabian | M | 15 | FSA | Thorax | ECT × 2 | PD |
| ED | F | 20 | Melanoma | Perianal | ECT × 3 | PR 36 |
BSH = British sport horse; CR = Complete remission; ECT = Electrochemotherapy; ED = English derived; FSA = Fibrosarcoma; ISH = Italian saddle horse; PD = Progressive disease; PR = Partial remission; SD = Stable disease.
Expressed in years.
Expressed in months.
ECT administered in multiple sessions.